The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT

J Ruanla, P Muangwong, K Kittidachanan, D Tippanya… - Brachytherapy, 2022 - Elsevier
Aim To evaluate the associations of vaginal dose parameters and incidence of vaginal
stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT) …

The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT

J Ruanla, P Muangwong, K Kittidachanan, D Tippanya… - 2022 - cmuir.cmu.ac.th
Aim: To evaluate the associations of vaginal dose parameters and incidence of vaginal
stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT) …

The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT.

J Ruanla, P Muangwong, K Kittidachanan… - …, 2022 - europepmc.org
Aim To evaluate the associations of vaginal dose parameters and incidence of vaginal
stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT) …

The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT

J Ruanla, P Muangwong, K Kittidachanan… - …, 2022 - brachyjournal.com
Aim To evaluate the associations of vaginal dose parameters and incidence of vaginal
stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT) …

The association of vagina equivalent dose in 2Gy fraction (EQD2) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT

J Ruanla, P Muangwong, K Kittidachanan… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim To evaluate the associations of vaginal dose parameters and incidence of vaginal
stenosis in patients with cervical cancer treated with image-guided brachytherapy (IGBT) …